MOTTIWALA AZIZ (Chief Commercial Officer) sold 17.5% of their position (13.06K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $892.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/19/2026ACC: 0001788542-26-000007
Officer· Chief Commercial Officer
Since Oct 2020
-13.06K
Net shares
Net seller
$892.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
13.06K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.29K
Price / share
$69.42
Trade value
$297.53K
% of position
5.8%
3/17/2026
74.54K→70.25K
Common Stock
Direct
Shares
−4.33K
Price / share
$68.71
Trade value
$297.51K
% of position
6.2%
3/18/2026
70.25K→65.92K
Common Stock
Direct
Shares
−4.44K
Price / share
$67.00
Trade value
$297.48K
% of position
6.7%
3/19/2026
65.92K→61.48K
Total
Net shares
−13.06K
Net value
-$892.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −4.29K | $69.42 | $297.53K | 5.8% | 74.54K | 70.25K |
| Common Stock Direct | 3/18/2026 | S · Sale | −4.33K | $68.71 | $297.51K | 6.2% | 70.25K | 65.92K |
| Common Stock Direct | 3/19/2026 | S · Sale | −4.44K | $67.00 | $297.48K | 6.7% | 65.92K | 61.48K |
| Total | −13.06K | -$892.53K | ||||||
Derivative Transactions0
No derivative transactions reported